首页> 外文期刊>AIDS >Moderate levels of preantiretroviral therapy drug resistance in a generalized epidemic: time for better first-line ART?
【24h】

Moderate levels of preantiretroviral therapy drug resistance in a generalized epidemic: time for better first-line ART?

机译:中等程度的预血管病毒治疗耐药在广义疫情中:时间为更好的一线艺术?

获取原文
获取原文并翻译 | 示例
           

摘要

Background: The WHO-recommended first-line antiretroviral therapy (ART) as a fixed dose combination (FDC) of efavirenz (EFV) and tenofovir disoproxil fumarate (TDF) with lamivudine (3TC) or emtricitabine (FTC) has been preferred in the large scale unprecedented ART roll out in Southern Africa. Models and recent reports suggest that pre-ART HIV drug resistance (PDR) is increasing with high treatment coverage.
机译:None

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号